Literature DB >> 30007055

Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice.

S Yu1,2, L Ding1,2, D Liang2, L Luo3.   

Abstract

Reprograming of metabolic pathways is critical in governing the polarization of macrophages into classical proinflammatory M1 or alternative anti-inflammatory M2 phenotypes in metabolic diseases, such as diabetes. Porphyromonas gingivalis, a keystone pathogen of periodontitis, causes an imbalance in M1/M2 activation, resulting in a hyperinflammatory environment that promotes the pathogenesis of periodontitis. However, whether P. gingivalis infection modulates metabolic pathways to alter macrophage polarization remains unclear. Bone-marrow-derived macrophages (BMDMs) were collected from 6-week-old female C57BL/6 mice and stimulated with P. gingivalis, P. gingivalis-derived LPS or IL-4. Relative gene expression and protein production were measured by quantitative real-time PCR, RNA sequencing and western blotting. Colorimetric assays were also performed to assess the amounts of α-ketoglutarate (α-KG) and succinate. P. gingivalis or P. gingivalis-derived LPS-induced inflammatory responses enhanced M1 macrophages and suppressed M2 macrophages, even in the presence of IL-4. P. gingivalis inhibited Idh1/2 and Gpt1/2 mRNA expression, and increased Akgdh mRNA expression, thus decreasing the ratio of α-KG/succinate. Supplementation of cell-permeable dimethyl-α-KG dramatically restored M2 activation during P. gingivalis infection. Our study suggests that P. gingivalis maintains a hyperinflammatory state by suppressing the production of α-KG by M2 macrophages.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Porphyromonas gingivaliszzm321990; macrophage polarization; periodontitis; α-ketoglutarate

Mesh:

Substances:

Year:  2018        PMID: 30007055     DOI: 10.1111/omi.12241

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  9 in total

Review 1.  Probiotics During the Therapeutic Management of Periodontitis.

Authors:  Flávia Furlaneto; Karin Hitomi Ishikawa; Michel Reis Messora; Marcia P A Mayer
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Polarization Profiles of T Lymphocytes and Macrophages Responses in Periodontitis.

Authors:  Franco Cavalla; Marcela Hernández
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Treponema denticola stimulates Oncostatin M cytokine release and de novo synthesis in neutrophils and macrophages.

Authors:  Megan M Jones; Stephen T Vanyo; Wael Ibraheem; Abhiram Maddi; Michelle B Visser
Journal:  J Leukoc Biol       Date:  2020-07-17       Impact factor: 4.962

Review 4.  The Regulatory Role of α-Ketoglutarate Metabolism in Macrophages.

Authors:  Shaojuan Liu; Jie Yang; Zhenfang Wu
Journal:  Mediators Inflamm       Date:  2021-03-29       Impact factor: 4.711

Review 5.  Interaction between genetic factors, Porphyromonas gingivalis and microglia to promote Alzheimer's disease.

Authors:  Ingar Olsen; Sim K Singhrao
Journal:  J Oral Microbiol       Date:  2020-09-16       Impact factor: 5.474

Review 6.  Macrophages: A communication network linking Porphyromonas gingivalis infection and associated systemic diseases.

Authors:  Jie Lin; Dingming Huang; Hongwei Xu; Fenghuang Zhan; XueLian Tan
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

Review 7.  Macrophages in periapical lesions: Potential roles and future directions.

Authors:  Yao Song; Xinying Li; Dingming Huang; Hongjie Song
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

Review 8.  Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects.

Authors:  An-Na Chen; Yan Luo; Yu-Han Yang; Jian-Tao Fu; Xiu-Mei Geng; Jun-Ping Shi; Jin Yang
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 9.  Innate Phagocyte Polarization in the Oral Cavity.

Authors:  Sarah Metcalfe; Natalie Anselmi; Alejandro Escobar; Michelle B Visser; Jason G Kay
Journal:  Front Immunol       Date:  2022-01-06       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.